Literature DB >> 19034645

A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins.

Siska Cochran1, Cai Ping Li, Vito Ferro.   

Abstract

A surface plasmon resonance-based solution affinity assay is described for measuring the K(d) of binding of heparin/heparan sulfate-binding proteins with a variety of ligands. The assay involves the passage of a pre-equilibrated solution of protein and ligand over a sensor chip onto which heparin has been immobilised. Heparin sensor chips prepared by four different methods, including biotin-streptavidin affinity capture and direct covalent attachment to the chip surface, were successfully used in the assay and gave similar K(d) values. The assay is applicable to a wide variety of heparin/HS-binding proteins of diverse structure and function (e.g., FGF-1, FGF-2, VEGF, IL-8, MCP-2, ATIII, PF4) and to ligands of varying molecular weight and degree of sulfation (e.g., heparin, PI-88, sucrose octasulfate, naphthalene trisulfonate) and is thus well suited for the rapid screening of ligands in drug discovery applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034645     DOI: 10.1007/s10719-008-9210-0

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  57 in total

1.  Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites.

Authors:  Birgit Goger; Yvonne Halden; Angelika Rek; Roland Mösl; David Pye; John Gallagher; Andreas J Kungl
Journal:  Biochemistry       Date:  2002-02-05       Impact factor: 3.162

2.  Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors.

Authors:  R Karlsson
Journal:  Anal Biochem       Date:  1994-08-15       Impact factor: 3.365

3.  Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas.

Authors:  R M Lozano; M Jiménez; J Santoro; M Rico; G Giménez-Gallego
Journal:  J Mol Biol       Date:  1998-09-04       Impact factor: 5.469

4.  NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer.

Authors:  K H Mayo; V Roongta; E Ilyina; R Milius; S Barker; C Quinlan; G La Rosa; T J Daly
Journal:  Biochemistry       Date:  1995-09-12       Impact factor: 3.162

5.  Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor.

Authors:  D B Volkin; A M Verticelli; K E Marfia; C J Burke; H Mach; C R Middaugh
Journal:  Biochim Biophys Acta       Date:  1993-11-10

6.  Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.

Authors:  J Watton; C Longstaff; D A Lane; T W Barrowcliffe
Journal:  Biochemistry       Date:  1993-07-20       Impact factor: 3.162

Review 7.  Enabling methodology for the end functionalization of glycosaminoglycan oligosaccharides.

Authors:  Emiliano Gemma; Odile Meyer; Dusan Uhrín; Alison N Hulme
Journal:  Mol Biosyst       Date:  2008-04-17

8.  Molecular mapping and functional characterization of the VEGF164 heparin-binding domain.

Authors:  Dominik Krilleke; Andrea DeErkenez; William Schubert; Indrajit Giri; Gregory S Robinson; Yin-Shan Ng; David T Shima
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

9.  Densimetric determination of equilibrium binding of sucrose octasulfate with basic fibroblast growth factor.

Authors:  T Arakawa; J Wen; J S Philo
Journal:  J Protein Chem       Date:  1993-12

10.  Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations.

Authors:  Sylvie Ricard-Blum; Olivier Féraud; Hugues Lortat-Jacob; Anna Rencurosi; Naomi Fukai; Fatima Dkhissi; Daniel Vittet; Anne Imberty; Bjorn R Olsen; Michel van der Rest
Journal:  J Biol Chem       Date:  2003-10-28       Impact factor: 5.157

View more
  11 in total

1.  Evolving the use of peptides as components of biomaterials.

Authors:  Joel H Collier; Tatiana Segura
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

2.  Interaction of thrombin with sucrose octasulfate.

Authors:  Bijoy J Desai; Rio S Boothello; Akul Y Mehta; J Neel Scarsdale; H Tonie Wright; Umesh R Desai
Journal:  Biochemistry       Date:  2011-07-18       Impact factor: 3.162

3.  Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides.

Authors:  Wenjing Zhao; Scott A McCallum; Zhongping Xiao; Fuming Zhang; Robert J Linhardt
Journal:  Biosci Rep       Date:  2012-02       Impact factor: 3.840

4.  VEGF internalization is not required for VEGFR-2 phosphorylation in bioengineered surfaces with covalently linked VEGF.

Authors:  Sean M Anderson; Bhupinder Shergill; Zachary T Barry; Eleana Manousiouthakis; Tom T Chen; Elliot Botvinick; Manu O Platt; M Luisa Iruela-Arispe; Tatiana Segura
Journal:  Integr Biol (Camb)       Date:  2011-08-08       Impact factor: 2.192

5.  Heparan Sulfate Mimicking Glycopolymer Prevents Pancreatic β Cell Destruction and Suppresses Inflammatory Cytokine Expression in Islets under the Challenge of Upregulated Heparanase.

Authors:  Ravi S Loka; Zhenfeng Song; Eric T Sletten; Yasmin Kayal; Israel Vlodavsky; Kezhong Zhang; Hien M Nguyen
Journal:  ACS Chem Biol       Date:  2022-06-04       Impact factor: 4.634

6.  The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy.

Authors:  K Dredge; E Hammond; K Davis; C P Li; L Liu; K Johnstone; P Handley; N Wimmer; T J Gonda; A Gautam; V Ferro; I Bytheway
Journal:  Invest New Drugs       Date:  2009-04-09       Impact factor: 3.850

7.  Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.

Authors:  Marco Rusnati; Antonella Bugatti; Stefania Mitola; Daria Leali; Paolo Bergese; Laura E Depero; Marco Presta
Journal:  Sensors (Basel)       Date:  2009-08-20       Impact factor: 3.576

8.  Granulin-epithelin precursor interacts with heparan sulfate on liver cancer cells.

Authors:  Chi Wai Yip; Phyllis F Y Cheung; Idy C Y Leung; Nicholas C L Wong; Christine K C Cheng; Sheung Tat Fan; Siu Tim Cheung
Journal:  Carcinogenesis       Date:  2014-08-12       Impact factor: 4.944

Review 9.  Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.

Authors:  Paola Chiodelli; Antonella Bugatti; Chiara Urbinati; Marco Rusnati
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

Review 10.  Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.

Authors:  Helena Crijns; Vincent Vanheule; Paul Proost
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.